Skip to content

Acadia Pharmaceuticals Inc

ACAD· NasdaqCore metricsCIK 1070494

Pharmaceutical preparations553 peers

Last sale
Nov 6, 2026 · +0.00%
Market cap
$3.67B
172.83M shares
Filings
1,015
$342.29M
Q3 2026+11.9% FY25 yoy
$53.52M
Q3 2026+72.7% FY25 yoy
$71.72M
Q3 2026−54.6% FY25 yoy
$134.72M
Q3 2026derived−33.1% FY25 yoy
$0.31
Q3 2026+69.1% FY25 yoy
$322.37M
Q3 2026−44.4% FY25 yoy
$3.67B
10.1×
3.0×
2.6×
2.24%
—

Twelve months to Sep 30, 2026 · derived

Price

$21.224.95%$1.11past year
Nov 6, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$1.07BFY 2025
$1.07B0FY 2014FY 2019FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$1,071,505,000reported
FY 20242024-12-31$957,797,000reported
FY 20232023-12-31$726,437,000reported
FY 20222022-12-31$517,235,000reported
FY 20212021-12-31$484,145,000reported
FY 20202020-12-31$441,755,000reported
FY 20192019-12-31$339,076,000reported
FY 20182018-12-31$223,807,000reported
FY 20172017-12-31$124,901,000reported
FY 20162016-12-31$17,331,000reported
FY 20152015-12-31$61,000reported
FY 20142014-12-31$120,000reported

Pharmaceutical preparations

Acadia Pharmaceuticals Inc is the 34th largest of the 554 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Acadia Pharmaceuticals Inc · CIK 1070494 · Engraved from SEC EDGAR